Correlation Between UNIQA INSURANCE and BridgeBio Pharma,

Can any of the company-specific risk be diversified away by investing in both UNIQA INSURANCE and BridgeBio Pharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining UNIQA INSURANCE and BridgeBio Pharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between UNIQA INSURANCE GR and BridgeBio Pharma,, you can compare the effects of market volatilities on UNIQA INSURANCE and BridgeBio Pharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UNIQA INSURANCE with a short position of BridgeBio Pharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of UNIQA INSURANCE and BridgeBio Pharma,.

Diversification Opportunities for UNIQA INSURANCE and BridgeBio Pharma,

0.36

Correlation Coefficient

UNIQA INSURANCE  BridgeBio Pharma,

Weak diversification

The 3 months correlation between UNIQA and BridgeBio is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding UNIQA INSURANCE GR and BridgeBio Pharma, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BridgeBio Pharma, and UNIQA INSURANCE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on UNIQA INSURANCE GR are associated (or correlated) with BridgeBio Pharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BridgeBio Pharma, has no effect on the direction of UNIQA INSURANCE i.e., UNIQA INSURANCE and BridgeBio Pharma, go up and down completely randomly.

Pair Corralation between UNIQA INSURANCE and BridgeBio Pharma,

Assuming the 90 days trading horizon UNIQA INSURANCE is expected to generate 1.32 times less return on investment than BridgeBio Pharma,. But when comparing it to its historical volatility, UNIQA INSURANCE GR is 1.17 times less risky than BridgeBio Pharma,. It trades about 0.17 of its potential returns per unit of risk. BridgeBio Pharma, is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  2,960  in BridgeBio Pharma, on April 22, 2025 and sell it today you would earn a total of  994.00  from holding BridgeBio Pharma, or generate 33.58% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

UNIQA INSURANCE GR  vs.  BridgeBio Pharma,

UNIQA INSURANCE GR

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in UNIQA INSURANCE GR are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, UNIQA INSURANCE unveiled solid returns over the last few months and may actually be approaching a breakup point.

BridgeBio Pharma,

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in BridgeBio Pharma, are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, BridgeBio Pharma, reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with UNIQA INSURANCE and BridgeBio Pharma,

The main advantage of trading using opposite UNIQA INSURANCE and BridgeBio Pharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UNIQA INSURANCE position performs unexpectedly, BridgeBio Pharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BridgeBio Pharma, will offset losses from the drop in BridgeBio Pharma,'s long position.

The idea behind UNIQA INSURANCE GR and BridgeBio Pharma, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.